The transition to a clinical company is probably the most adventurous and riskiest step in the life of a biotech company. Get it right the first time!
In a casual and relaxed environment, (to-be) founders can learn from seasoned entrepreneurs and industry experts, make valuable contacts and gain insights into how to improve their project’s chances of success.
Whether you are a company with a pipeline of preclinical assets, a nascent start-up, or a researcher working on the next innovation on the verge of spinning out, this Biotech NetWorkshop is for you.
Join us on 28 - 29 June 2017, at the conference centre MS-Weitblick in Munich!
- Networking event for to-be entrepreneurs, new founders and management of established startups
- Impressive line-up of speakers from big pharma, biotech, regulatory authorities and the investment community
- Rooftop summer reception with spectacular views of Munich
The event is jointly organized by Ascenion and Max Planck Innovation who have actively supported the foundation of over 80 spin-offs.